You are here: Industry Insights > IPO

News List

Denali pulls off 2017’s biggest biotech IPO, pocketing $250M for Parkinson’s, Alzheimer’s trials iercebiotech
December 11, 2017
Denali Therapeutics has raised $250 million. The IPO, the biggest biotech listing of the year, sets Denali up to push drugs against Alzheimer’s and Parkinson’s diseases through early clinical trials.
Nightstar files for $86M IPO to fund gene therapy trials fiercebiotech
September 05, 2017
The money will equip Nightstar to complete a phase 3 trial of its choroideremia gene therapy and advance two other eye disease candidates through early-stage clinical studies.
Accelerated Pharma puts the brakes on IPO fiercebiotech
August 25, 2017
The biotech had originally planned a $17M IPO in October last year.
Celgene drops Sutro buyout option and refocuses deal on 4 I-O programs, freeing partner to pursue ne fiercebiotech
August 11, 2017
Celgene gained the Sutro buyout option after paying $95 million and committing to $1 billion more in 2014.
Celltrion eyes product and sales expansion after IPO biospectrumasia
July 18, 2017
The company plans to leverage the new funds generated by the initial public offering to expand its direct sales networks overseas
Deals this week: Shenzhen Kangtai Biological Products, Telix Pharmaceuticals, Fresenius Finance Irel pharmaceutical-technology
January 22, 2017
Chinese vaccine and biologic products developer and manufacturer Shenzhen Kangtai Biological Products has announced the pricing for an initial public offering (IPO) of shares to raise ¥138.2m ($20.08m) in gross proceeds.

Previous page 1 2 3 4 5 6 7 8 9 Next page